Article
[Fabry disease (alpha-galactosidase deficiency)].
Nihon rinsho. Japanese journal of clinical medicine - 1 Dec 1995
Okumiya T, Sakuraba H
Abstract excerpt
Fabry disease is an X-linked glycosphingolipid storage disorder resulting from a deficiency of lysosomal alpha-galactosidase (alpha-Gal; EC 3.2.1.22). Classical form patients, with clinical manifestations of generalized angiopathy of early onset, usually show no detectable alpha-Gal activity. The...
Topics
- Analgesics, Non-Narcotic
- Carbamazepine
- Fabry Disease
- Humans
- Lysosomes
- Mutation
- alpha-Galactosidase
